Enzyme-activatable fluorescent probes for β-galactosidase: from design to biological applications.
Yongkang YaoYutao ZhangChenxu YanWei-Hong ZhuZhi-Qian GuoPublished in: Chemical science (2021)
β-Galactosidase (β-gal), a typical hydrolytic enzyme, is a vital biomarker for cell senescence and primary ovarian cancers. Developing precise and rapid methods to monitor β-gal activity is crucial for early cancer diagnoses and biological research. Over the past decade, activatable optical probes have become a powerful tool for real-time tracking and in vivo visualization with high sensitivity and specificity. In this review, we summarize the latest advances in the design of β-gal-activatable probes via spectral characteristics and responsiveness regulation for biological applications, and particularly focus on the molecular design strategy from turn-on mode to ratiometric mode, from aggregation-caused quenching (ACQ) probes to aggregation-induced emission (AIE)-active probes, from near-infrared-I (NIR-I) imaging to NIR-II imaging, and from one-mode to dual-mode of chemo-fluoro-luminescence sensing β-gal activity.
Keyphrases
- living cells
- fluorescent probe
- fluorescence imaging
- photodynamic therapy
- high resolution
- small molecule
- single molecule
- quantum dots
- dna damage
- single cell
- stem cells
- optical coherence tomography
- positron emission tomography
- squamous cell carcinoma
- nitric oxide
- oxidative stress
- magnetic resonance
- high speed
- cell therapy
- squamous cell
- stress induced
- endothelial cells
- combination therapy
- locally advanced